Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 4/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | HPGD | P15428 | 3/20 | 0.48 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.48 |
| ▸ | GSK3B | P49841 | 3/20 | 0.47 |
| ▸ | IDO1 | P14902 | 1/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.45 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.45 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | AR | P10275 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17694987 | 0.95 | MAPT (0.52) | MAPTLMNAMEN1KMT2AALDH1A1 | |
| SCHEMBL24589786 | 0.95 | MAPT (0.52) | MAPTLMNAMEN1KMT2AALDH1A1 | |
| SCHEMBL17694986 | 0.95 | MAPT (0.52) | MAPTLMNAMEN1KMT2AALDH1A1 | |
| SCHEMBL17269499 | 0.88 | MAPT (0.50) | MAPTLMNAMEN1KMT2AALDH1A1 | |
| SCHEMBL19219087 | 0.87 | MEN1 (0.63) | MAPTLMNAMEN1KMT2AALDH1A1 | |
| SCHEMBL17945300 | 0.87 | MEN1 (0.63) | MAPTLMNAMEN1KMT2AALDH1A1 | |
| SCHEMBL17694981 | 0.87 | MEN1 (0.63) | MAPTLMNAMEN1KMT2AALDH1A1 | |
| SCHEMBL17694973 | 0.87 | MEN1 (0.63) | MAPTLMNAMEN1KMT2AALDH1A1 | |
| SCHEMBL17343377 | 0.86 | MAPT (0.48) | MAPTLMNAMEN1KMT2AALDH1A1 | |
| SCHEMBL24590021 | 0.85 | KMT2A (0.61) | MAPTLMNAMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250214961-A1 | PYRIDINIUM DERIVATIVES MADE BY HYDROTHERMAL SYNTHESIS FOR USE AS ANOLYTES IN ELECTROCHEMICAL CELLS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2025-07-03 | — | — | US | disclosed |
| US-12291513-B2 | Pyridinium derivatives made by hydrothermal synthesis for use as anolytes in electrochemical cells | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2025-05-06 | — | — | US | disclosed |
| CN-117561239-A | Pyridinium derivatives prepared by hydrothermal synthesis for use as anode electrolytes in electrochemical cells | 威斯康星州男校友研究基金会 | 2024-02-13 | — | — | CN | disclosed |
| EP-4288415-A1 | PYRIDINIUM DERIVATIVES MADE BY HYDROTHERMAL SYNTHESIS FOR USE AS ANOLYTES IN ELECTROCHEMICAL CELLS | Wisconsin Alumni Research Foundation (US) | 2023-12-13 | — | — | EP | disclosed |
| US-20220363663-A1 | PYRIDINIUM DERIVATIVES MADE BY HYDROTHERMAL SYNTHESIS FOR USE AS ANOLYTES IN ELECTROCHEMICAL CELLS | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2022-11-17 | — | — | US | disclosed |
| WO-2022236241-A1 | PYRIDINIUM DERIVATIVES MADE BY HYDROTHERMAL SYNTHESIS FOR USE AS ANOLYTES IN ELECTROCHEMICAL CELLS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2022-11-10 | — | — | WO | disclosed |
| US-9520570-B2 | Organic electronic device and method for the production thereof | OSRAM OLED GMBH (DE) | 2016-12-13 | — | — | US | disclosed |
| US-9520570-B2 | Organic electronic device and method for the production thereof | OSRAM OLED GMBH (DE) | 2016-12-13 | — | — | US | disclosed |
| EP-2483945-B1 | ORGANIC ELECTRONIC DEVICE AND METHOD FOR THE PRODUCTION THEREOF | OSRAM OLED GMBH (DE) | 2016-11-02 | — | — | EP | disclosed |
| EP-2342772-B1 | ORGANIC ELECTRONIC COMPONENT AND METHOD FOR THE PRODUCTION THEREOF | OSRAM OLED GMBH (DE) | 2015-12-02 | — | — | EP | disclosed |
| US-8558223-B2 | Organic electronic component and method for the production thereof | OSRAM OPTO SEMICONDUCTORS GMBH (DE) | 2013-10-15 | — | — | US | disclosed |
| US-8558223-B2 | Organic electronic component and method for the production thereof | OSRAM OPTO SEMICONDUCTORS GMBH (DE) | 2013-10-15 | — | — | US | disclosed |
| US-20120286253-A1 | Organic Electronic Device and Method for the Production Thereof | OSRAM OLED GMBH (DE) | 2012-11-15 | — | — | US | disclosed |
| US-20120286253-A1 | Organic Electronic Device and Method for the Production Thereof | OSRAM OLED GMBH (DE) | 2012-11-15 | — | — | US | disclosed |
| WO-2011039323-A2 | ORGANIC ELECTRONIC DEVICE AND METHOD FOR THE PRODUCTION THEREOF | OSRAM OPTO SEMICONDUCTORS GMBH (DE) | 2011-04-07 | — | — | WO | disclosed |
| WO-2010034304-A2 | ORGANIC ELECTRONIC COMPONENT AND METHOD FOR THE PRODUCTION THEREOF | OSRAM OPTO SEMICONDUCTORS GMBH (DE) | 2010-04-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220363663-A1 | PYRIDINIUM DERIVATIVES MADE BY HYDROTHERMAL SYNTHESIS FOR USE AS ANOLYTES IN ELECTROCHEMICAL CELLS | PDXK, PNPO, ANO2 | MAPT 2168/4885LMNA 2300/4885MEN1 2089/4885 |
| US-20250214961-A1 | PYRIDINIUM DERIVATIVES MADE BY HYDROTHERMAL SYNTHESIS FOR USE AS ANOLYTES IN ELECTROCHEMICAL CELLS | PDXK, PNPO, ANO2 | MAPT 2168/4885LMNA 2300/4885MEN1 2089/4885 |
| US-12291513-B2 | Pyridinium derivatives made by hydrothermal synthesis for use as anolytes in electrochemical cells | PDXK, PNPO, ANO2 | MAPT 2168/4885LMNA 2300/4885MEN1 2089/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.